Debra Miller discusses Duchenne muscular dystrophy





The interactive transcript could not be loaded.



Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Uploaded on Feb 24, 2009

BIOtech Now interviews Debra Miller, co-founder of CureDuchenne.

CureDuchenne is a non-profit organization founded in 2003 by Debra and Paul Miller, parents of a Duchenne boy. CureDuchennes vision is its name to cure Duchenne muscular dystrophy. CureDuchenne aggressively seeks the most promising, leading edge research breakthroughs and expedites them to the clinical trial process. The ultimate goalgive the boys that have Duchenne now a chance to live a normal life by expediting the cure and/or the availability of therapies that can give quality of life to Duchenne boys, much like insulin does for diabetics.

  • Category

  • License

    • Standard YouTube License


  1. 1

    BioDigest: Biotechnology and Rare Diseases

  2. 2

    BioBytes: Biotechnology and Vaccines

  3. 3

    BioBytes: What are biosimilars?

  4. 4

    BioDigest: Geron

  5. 5

    BioByte - Biotechnology and the Flu Pandemic

  6. 6

    BioBytes 108 - What are Stem Cells?

  7. 7

    BioBytes 104 - What is personalized medicine?

  8. 8

    BioByte 103 - What are biotech drugs?

  9. 9

    Bioinformatics Allows a Virtual Tour of the Human Body

  10. Debra Miller discusses Duchenne muscular dystrophy

  11. 11

    Dr. Howard Fillit Discusses Alzheimers Disease

  12. 12

    Kristofer Prepelica, PhD Discusses Lymphoma Research

  13. 13

    RNA Interference

  14. 14

    Alzheimer's: Searching for a Cure

  15. 15


  16. 16


  17. 17


  18. 18

    Searching for New Drugs in the Amazon

  19. 19

    Gene Therapy - Cortical Studios

  20. 20

    BioBytes: What are biosimilars?

  21. 21

    TIME IS NOT NEUTRAL FOR US ..... World Parkinson's Congress video entry

  22. 22

    Biotechnology Industry Organization: For Innovation, For Industry, For You!

Sign in to add this to Watch Later

Add to